Literature DB >> 19279546

An unusual case of colonic ischemia.

Fouad J Moawad1, Lawrence Goldkind.   

Abstract

Sumatriptan is widely prescribed for the treatment of migraine headaches. Its actions are mediated via agonist action on the vascular 5-hydroxytryptamine 1 receptor which results in vasoconstriction. We report a case of a 46-year-old woman who developed ischemic colitis while taking increasing doses of sumatriptan for a migraine headache. Her only other medication was oral contraceptives. Interestingly, a potential synergistic action between the two medications may exist since estrogen reduces triptan clearance through its action on monamine oxide, an enzyme that metabolizes serotonin. Sumatriptan should be recognized as an important cause of drug-induced colonic ischemia, especially in patients taking estrogen.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19279546     DOI: 10.1097/SMJ.0b013e318191b741S

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  4 in total

1.  ACG clinical guideline: epidemiology, risk factors, patterns of presentation, diagnosis, and management of colon ischemia (CI).

Authors:  Lawrence J Brandt; Paul Feuerstadt; George F Longstreth; Scott J Boley
Journal:  Am J Gastroenterol       Date:  2014-12-23       Impact factor: 10.864

Review 2.  Sumatriptan-associated ischemic colitis: case report and review of the literature and FAERS.

Authors:  Thuc Quyen Nguyen; James H Lewis
Journal:  Drug Saf       Date:  2014-02       Impact factor: 5.606

3.  Nicorandil associated colonic ulceration: case series of an increasingly recognized complication.

Authors:  Bee C Lee; Patrick B Allen; Grant R Caddy; Inder Mainie
Journal:  Dig Dis Sci       Date:  2011-03-06       Impact factor: 3.199

4.  Isolated naratriptan-associated ischemic colitis.

Authors:  Asra Akbar; George Nissan; Priyanka Chaudhry; Priya Rangasamy; Steven Mudrovich
Journal:  Proc (Bayl Univ Med Cent)       Date:  2016-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.